Supporting discoveries since 1987

Aug
25

The CHTN mission is to provide prospectively procured biospecimens to scientific investigators with the ability to modify procurement and specimen processing procedures to suit the individual protocol of each investigator. Basic demographic information and clinicopathologic data abstracted from pathology reports are provided to investigators. More detailed clinical annotation may be obtained by arrangement.

Most tissue specimens procured by the CHTN are distributed to investigators as fresh/viable aliquots or snap-frozen. Quality control (QC) for all tissue samples consists of histologic analysis of a paired formalin-fixed paraffin-embedded (FFPE) tissue segment that is examined by a board-certified anatomic pathologist ensuring the delivery of correct tissue type and the elimination of highly necrotic specimens (Fig. A).

For tumor specimens, tumor cellularity, percent stroma and percent necrosis are also recorded (Fig. B). The histologic QC procedures created by the... Read more

biospecimenscancer researchquality assurancehistologyhistologic QCtumor cellularity